There is an error in the ATS clinical practice guidelines published in the August 1, 2019, issue of the Journal (1). The ATS recommendations in response to Question 4 (“Should hospitalized adults suspected of having OHS, in whom the diagnosis has not yet been made, be discharged from the hospital with or without PAP treatment until the diagnosis of OHS is either confirmed or ruled out?”) should begin with the words “We suggest. . .” This correction should have been made to page e17 of the full document and page 287 of the Executive Summary. Table 1 in both documents does include the correct wording.
The full recommendation should read:
We suggest that hospitalized patients suspected of having OHS be started on NIV therapy before being discharged from the hospital and continued on NIV therapy until they undergo outpatient workup and titration of PAP therapy in the sleep laboratory, ideally during the first 3 months after hospital discharge (conditional recommendation, very low level of certainty in the evidence).
Reference
- 1.Mokhlesi B, Masa JF, Brozek JL, Gurubhagavatula I, Murphy PB, Piper AJ, Tulaimat A, Afshar M, Balachandran JS, Dweik RA, Grunstein RR, Hart N, Kaw R, Lorenzi-Filho G, Pamidi S, Patel BK, Patil SP, Pépin JL, Soghier I, Kakazu MT, Teodorescu M on behalf of the American Thoracic Society Assembly on Sleep and Respiratory Neurobiology. Evaluation and management of obesity hypoventilation syndrome. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019;200:e6–e24. doi: 10.1164/rccm.201905-1071ST. [DOI] [PMC free article] [PubMed] [Google Scholar]
